Accelovance, Inc.,

Accelovance, Inc.,

headquartered in Rockville, MD, is an award-winning Contract Research Organization (CRO) focused primarily in early phase oncology, vaccines, and general medicine. As a clinical services provider to the pharmaceutical and biotechnology industries, Accelovance offers comprehensive clinical development services including management and implementation of Phase I-IV clinical trials and a Clinical Call Center used for recruitment, post-marketing surveillance, and long-term survival follow-up. For more information, visit the company’s Web site at http://www.accelovance.com.

Press Contact: Michael Keens, VP Business Development
240.238.4941
mkeens@accelovance.com
Twitter: @Accelovance

Logo – http://photos.prnewswire.com/prnh/20140219/DC68221LOGO

SOURCE Accelovance

Photo:http://photos.prnewswire.com/prnh/20140219/DC68221LOGO
http://photoarchive.ap.org/
Accelovance

Web Site: http://www.accelovance.com

Former VP, Oncology, from Pfizer and Otsuka Joins Accelovance to Augment Oncology Growth

http://www.accelovance.com/news_events/pdf/Former%20VP%20Oncology%20from%20Pfizer%20and%20Otsuka%20Joins%20Accelovance%20to%20Augment%20Oncology%20Growth.pdf